CLINICAL TRIALS PROFILE FOR ESTRADERM
✉ Email this page to a colleague
All Clinical Trials for ESTRADERM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00386022 ↗ | The Effects of Aging and Estrogen on the Pituitary | Unknown status | National Institute on Aging (NIA) | Phase 2/Phase 3 | 2002-01-01 | The purpose of this study is to study the effects of aging and estrogen on the brain. Specifically, this study will examine how the hypothalamus signals the pituitary gland to secrete reproductive hormones and how that changes with aging. |
NCT00386022 ↗ | The Effects of Aging and Estrogen on the Pituitary | Unknown status | Massachusetts General Hospital | Phase 2/Phase 3 | 2002-01-01 | The purpose of this study is to study the effects of aging and estrogen on the brain. Specifically, this study will examine how the hypothalamus signals the pituitary gland to secrete reproductive hormones and how that changes with aging. |
NCT01268046 ↗ | Aging and Estrogen on Cortical Function | Completed | National Institute on Aging (NIA) | Phase 1/Phase 2 | 2009-11-01 | This study will focus on how estrogen affects parts of the brain associated with memory and how the effect of estrogen is altered with aging in postmenopausal women. |
NCT01268046 ↗ | Aging and Estrogen on Cortical Function | Completed | Massachusetts General Hospital | Phase 1/Phase 2 | 2009-11-01 | This study will focus on how estrogen affects parts of the brain associated with memory and how the effect of estrogen is altered with aging in postmenopausal women. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ESTRADERM
Condition Name
Clinical Trial Locations for ESTRADERM
Trials by Country
Clinical Trial Progress for ESTRADERM
Clinical Trial Phase
Clinical Trial Sponsors for ESTRADERM
Sponsor Name